Genomic Vision (GV.PA) Stock Price, Quote, News and Overview
EPA:GV - Euronext Paris - Matif - FR0011799907 - Common Stock - Currency: EUR
GV.PA Quote, Performance and Key Statistics
EPA:GV (11/3/2023, 7:00:00 PM)
0.0018
+0 (+5.88%)
The current stock price of GV.PA is 0.0018 EUR. In the past month the price decreased by -37.93%. In the past year, price decreased by -97.79%.
GV.PA Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| 4AB.DE | ABBVIE INC | 18.88 | 304.97B | ||
| AMG.DE | AMGEN INC | 13.37 | 132.64B | ||
| GIS.DE | GILEAD SCIENCES INC | 13.21 | 113.16B | ||
| 1GILD.MI | GILEAD SCIENCES INC | 12.65 | 108.39B | ||
| VX1.DE | VERTEX PHARMACEUTICALS INC | N/A | 98.73B | ||
| 1REGN.MI | REGENERON PHARMACEUTICALS | 11.87 | 52.64B | ||
| ARGX.BR | ARGENX SE | 104.99 | 30.45B | ||
| 22UA.DE | BIONTECH SE-ADR | N/A | 20.88B | ||
| IDP.DE | BIOGEN INC | 7.52 | 15.50B | ||
| 0QF.DE | MODERNA INC | N/A | 8.75B | ||
| 1MRNA.MI | MODERNA INC | N/A | 8.14B | ||
| BIO.DE | BIOTEST AG | 65.54 | 1.69B |
Related stock screener links
About GV.PA
Company Profile
Génomic Vision SA is a molecular diagnostics and technology company, which develops and commercializes research tools and tests for the early detection of cancers and genetic diseases. The company is headquartered in Bagneux, Ile-De-France and currently employs 37 full-time employees. The company went IPO on 2014-04-02. The company develops and commercializes single-DNA molecule diagnostic tests and research tools for life sciences, cancer and genetic diseases. The firm uses the molecular combining technique for the direct visualization of single DNA molecules to detect quantitative and qualitative changes in the genome landscape and establish their contribution to pathology. The company develops its products and services in three main markets: the medical diagnostic market focusing on DNA diagnostics (cancer genomics, genetic diseases); the pharmaceutical research and development market in the fields of genomics, to develop tests that can help physicians identify how patients are likely to respond to targeted therapies (personalized medicine, pharmacogenomics, cancer cell proliferation); and the academic laboratories research market, providing molecular combining tools for academic research in the field of cancer genetics, cytogenetics and DNA replication.
Company Info
Genomic Vision
Green Square Batiment E, 80-84 rue des Meuniers
Bagneux ILE-DE-FRANCE FR
Employees: 37
Phone: 33149080740.0
Genomic Vision / GV.PA FAQ
What is the stock price of Genomic Vision today?
The current stock price of GV.PA is 0.0018 EUR. The price increased by 5.88% in the last trading session.
What is the ticker symbol for Genomic Vision stock?
The exchange symbol of Genomic Vision is GV and it is listed on the Euronext Paris - Matif exchange.
On which exchange is GV.PA stock listed?
GV.PA stock is listed on the Euronext Paris - Matif exchange.
What is Genomic Vision worth?
Genomic Vision (GV.PA) has a market capitalization of 693.19K EUR. This makes GV.PA a Nano Cap stock.
How many employees does Genomic Vision have?
Genomic Vision (GV.PA) currently has 37 employees.
Should I buy Genomic Vision (GV.PA) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of GV.PA, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of GV.PA, evaluating the profitability, health, valuation and growth aspects
- Genomic Vision (GV.PA) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- Genomic Vision (GV.PA) Sales and EPS estimates to see what analysts future expectations are.
- Genomic Vision (GV.PA) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- Genomic Vision (GV.PA) Insider and Institutional Ownership to learn about the owners and their transactions.
- Genomic Vision (GV.PA) Stock Chart to make your own analysis
- Genomic Vision (GV.PA) Latest news and press-releases to stay up to date.
Does Genomic Vision (GV.PA) stock pay dividends?
GV.PA does not pay a dividend.
What is the Price/Earnings (PE) ratio of Genomic Vision (GV.PA)?
Genomic Vision (GV.PA) does not have a PE ratio as the earnings reported over the last twelve months were negative (-0.11).
GV.PA Technical Analysis
GV.PA Financial Highlights
Over the last trailing twelve months GV.PA reported a non-GAAP Earnings per Share(EPS) of -0.11. The EPS decreased by -14.12% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -268.44% | ||
| ROE | N/A | ||
| Debt/Equity | N/A |
GV.PA Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 35% to GV.PA. The Buy consensus is the average rating of analysts ratings from 8 analysts.